0000920465-19-000011.txt : 20190109
0000920465-19-000011.hdr.sgml : 20190109
20190109212945
ACCESSION NUMBER: 0000920465-19-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190107
FILED AS OF DATE: 20190109
DATE AS OF CHANGE: 20190109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TIDMARSH GEORGE F
CENTRAL INDEX KEY: 0001287235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 19519168
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wf-form4_154708736639403.xml
FORM 4
X0306
4
2019-01-07
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001287235
TIDMARSH GEORGE F
C/O LA JOLLA PHARMACEUTICAL COMPANY,
4550 TOWNE CENTRE COURT
SAN DIEGO
CA
92121
1
1
0
0
President, CEO & Secretary
Common Stock
2019-01-07
4
P
0
82
5.85
A
1281408
D
Common Stock
2019-01-07
4
P
0
287
5.85
A
1281695
D
Common Stock
2019-01-07
4
P
0
98
5.85
A
1281793
D
Common Stock
2019-01-07
4
P
0
397
5.85
A
1282190
D
Common Stock
2019-01-07
4
P
0
700
5.85
A
1282890
D
Common Stock
2019-01-07
4
P
0
436
5.85
A
1283326
D
Common Stock
22000
I
By children
/s/ Ryan Murr, as attorney-in-fact for George F. Tidmarsh
2019-01-09